Qingdao Vland Biotech Co Ltd (603739) — Cash Flow-to-Debt Ratio
Qingdao Vland Biotech Co Ltd (603739) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of CN¥24.29 Million could theoretically repay 0% of its total liabilities (CN¥1.14 Billion) in one year. Check Qingdao Vland Biotech Co Ltd (603739) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Qingdao Vland Biotech Co Ltd Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for Qingdao Vland Biotech Co Ltd across 11 annual periods. Also explore balance sheet size of Qingdao Vland Biotech Co Ltd for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Qingdao Vland Biotech Co Ltd (2014–2024)
Year-by-year debt coverage analysis for Qingdao Vland Biotech Co Ltd. For market capitalisation and broader financial context, see Qingdao Vland Biotech Co Ltd (603739) total market value.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.18x | CN¥195.41 Million | CN¥1.11 Billion | ▲ +38.4% |
| 2023 | 0.13x | CN¥153.59 Million | CN¥1.21 Billion | ▲ +12.7% |
| 2022 | 0.11x | CN¥95.31 Million | CN¥844.93 Million | ▼ -32.4% |
| 2021 | 0.17x | CN¥89.51 Million | CN¥536.18 Million | ▼ -67.6% |
| 2020 | 0.51x | CN¥173.00 Million | CN¥336.22 Million | ▲ +96.1% |
| 2019 | 0.26x | CN¥65.33 Million | CN¥248.99 Million | ▼ -3.9% |
| 2018 | 0.27x | CN¥85.75 Million | CN¥313.94 Million | ▼ -34.8% |
| 2017 | 0.42x | CN¥121.90 Million | CN¥291.02 Million | ▼ -26.8% |
| 2016 | 0.57x | CN¥154.49 Million | CN¥269.96 Million | ▲ +132.9% |
| 2015 | 0.25x | CN¥74.27 Million | CN¥302.27 Million | ▲ +37.9% |
| 2014 | 0.18x | CN¥58.55 Million | CN¥328.53 Million | — |